S100A1 gene transfer in myocardium

European Journal of Medical Research

Volumn 11, Issue 10, 2006, Pages 418-422

  Pleger, Sven T ^a,b   Most, P ^a,b   Heidt, B ^b   Voelkers, M ^b   Hata, J A ^c   Katus, H A ^b   Remppis, A ^b   Koch, W J ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Contractile function; Gene therapy; Myocardium; S1000A1

Indexed keywords

CALCIUM BINDING PROTEIN; GREEN FLUORESCENT PROTEIN; ISOPRENALINE; PROTEIN S100A1; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ADENOVIRUS VECTOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFICACY; FEASIBILITY STUDY; GENE OVEREXPRESSION; GENE TRANSFER; HEART CONTRACTION; HEART EJECTION FRACTION; HEART FUNCTION TEST; HEART LEFT VENTRICLE DP-DT; HEART MUSCLE; IN VIVO STUDY; MALE; NONHUMAN; PROTEIN EXPRESSION; RABBIT; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; VIRUS PARTICLE;

ADENOVIRIDAE; ANIMALS; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; INJECTIONS; MALE; MYOCARDIAL CONTRACTION; MYOCARDIUM; RABBITS; S100 PROTEINS; VENTRICULAR FUNCTION, LEFT;

EID: 33751073932     PISSN: 09492321     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. American Heart Association, 2004 Heart Disease and Stroke Statistics. www.americanheart.org.
2. Cohn JN, Bristow MR, Chien KR, Colucci WS, Frazier OH, Leinwand LA, Lorell BH, Moss AJ, Sonnenblick EH, Walsh RA, Mockrin SC, Reinlib L. Report of the National Heart, Lung, and Blood Institute Special Emphasis Panel on Heart Failure Research. Circulation. 1997; 95: 766-70.
3. Wehrens XHT, Marks AR. Altered function and regulation of cardiac ryanodine receptors in cardiac disease. Trends in Biochem Sci. 2003; 28:671-678.
4. Houser SR, Piacentino V, Weisser J. Abnormalities of calcium cycling in the hypertrophied and failing heart. J Mol Cell Cardiol. 2000; 32:1595-1607.
5. Dash B, Kadambi VJ, Schmidt AG, Tepe NM, Biniakiewicz D, Gerst MJ, Canning AM, Abraham WT, Hoit BD, Liggett SB, Lorenz JN, Dorn GW, Kranias EG. Interactions between phospholamban and β-adrenergic drive may lead to cardiomyopathy and early mortality. Circulation. 2001; 103:889-896.
6. Beuckelmann DJ., Nabauer M., Erdmann E. Intracellular calcium handling in isolatedventricular myocytes from patients with terminal heart failure. Circulation. 1992; 85: 1046-1055.
7. Kato K, Kimura S. S100ao (alpha alpha) protein is mainly located in the heart and striated muscles. Biochim Biophys Acta. 1985; 842:146-150.
8. 2+-binding protein S100A1 in human cardiomyopathy. Biochim Biophys Acta. 1996; 1313:253-257.
9. 2+ binding protein S100A1 in chronic pulmonary hypertension. Biochim Biophys Acta. 2000; 1500:249-255.
10. Most P, Pleger ST, Volkers M, Heidt B, Boerries M, Weichenhan D, Loffler E, Janssen PM, Eckhart AD, Martini J, Williams ML, Katus HA, Remppis A, Koch WJ. Cardiac adenoviral S100A1 gene delivery rescues failing myocardium. J Clin Invest. 2004; 114:1550-63.
11. Most P, Ehlermann P, Bernotat J, Pleger ST, Borries M, Reppel M, Mandinova A, Niroomand F, Pieske B, Janssen PML, Zeitz O, Eschenhagen T, Karczewski P, Smith GL, Koch WJ, Kattus HA, Remppis A: S100A1. A novel regulator of myocardial contractility. Proc Natl Acad Sci USA. 2001; 98:13889-12894.
12. 2+ cycling in rat cardiac myocytes. Basic Res Cardiol. 2002; 97:I/56-I/62.
13. Remppis A, Pleger ST, Most P, Lindenkamp J, Ehlermann P, Schweda C, Loffler E, Weichenhan D, Zimmermann W, Eschenhagen T, Koch WJ, Katus HA: Genetic modification of engineered heart tissue (EHT). S100A1 gene transfer strengthens EHT. J Gene Med. 2004; 6:387-94.
14. 2+ binding protein S100A1 in the heart leads to increased in vivo myocardial contractile performance. J Biol Chem. 2003; 278: 33809-33817.
15. He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, Vogelstein B. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci. USA 1998;95:2509-2514.
16. Maurice JP, Hata JA, Shah AS, White DC, McDonald PH, Dolber PC, Wilson KH, Lefkowitz RJ, Glower DD, Koch WJ. Enhancement of cardiac function after adenoviral-mediated in vivo intracoronary b2-adrenergic receptor gene delivery. J.Clin. Invest. 1999; 104:21-29.
17. 2+-binding protein S100A1 from myocardium and recombinant Escherichia coli. J Chromatography B 2000;737:39-45.
18. Pleger ST, Remppis A, Heidt B, Völkers M, Chuprun JK, Kuhn M, Zhou RH, Gao E, Szabo G, Weichenhan D, Müller OJ, Eckhart AD, Katus HA, Koch WJ, Most P. S100A1 gene therapy preserves in vivo cardiac function after myocardial infarction. Mol Ther. 2005 Dec;12(6): 1120-9.
19. Kettlewell S, Most P, Currie S, Koch WJ, Smith GL. S100A1 increases the gain of excitation-contraction coupling in isolated rabbit ventricular cardiomyocytes. J Mol Cell Cardiol. 2005 Dec;39(6):900-10.
20. Most P, Seifert H, Gao E, Völkers M, Heierhorst J, Remppis A, Pleger ST, DeGeorge BR Jr, Eckhart AD, Feldman AM, Koch WJ. Cardiac S100A1 protein levels determine contractile performance and propensity toward heart failure after myocardial infarction. Circulation. 2006 Sep 19;114(12):1258-68.
21. Völkers M, Loughrey CM, Macquaide N, Remppis A, DeGeorge B, Wegner FV, Friedrich O, Fink RH, Koch WJ, Smith GL, Most P. S100A1 decreases calcium spark frequency and alters their spatial characteristics in permeabilized adult ventricular cardiomyocytes. Cell Calcium. 2006 Aug 17; Epub ahead of print.
22. Du XJ, Cole TJ, Tenis N, Gao XM, Kontgen F, Kemp BE, Heierhorst J. Impaired cardiac contractility response to hemodynamic stress in S100A1-deficient mice. Mol Cell Biol. 2002; 22:2821-2829.
23. Chan SY, Li K, Piccotti JR, et al. Tissue-specific consequences of the anti-adenoviral immune response: implications for cardiac transplants. Nat Med. 1999; 5: 1143-9.
24. Jooss K and N Chirmule. Immunity to adenovirus and adeno-associated viral vectors. implications for gene therapy. Gene Therapy. 2003; 10: 955-963.
25. Grimm D and Kleinschmidt JA. Progress in adeno-associated virus type 2 vector production: Promises and prospects for clinical use. Hum Gene Ther. 1999; 10: 2445-2450.